Silencing of Fem1c R3 gene expression in the DBA/2J mouse precedes retinal ganglion cell death and is associated with histone deacetylase activity

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 3, 2012, Pages 1428-1435

  Pelzel, Heather R ^a,b   Schlamp, Cassandra L ^a   Waclawski, Michael ^a   Shaw, Malissa K ^a   Nickells, Robert W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN WHITEWATER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 3; HISTONE H4; PROTEIN BAX; TRICHOSTATIN A; DNA BINDING PROTEIN; FEM1C PROTEIN, MOUSE; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; TRANSCRIPTION FACTOR;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE SILENCING; GLAUCOMA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MOUSE; NERVE DEGENERATION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RETINA GANGLION CELL; ROSA3 GANGLION CELL REPORTER GENE; ACETYLATION; ANIMAL; CHROMATIN; DBA MOUSE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OPTIC NERVE DISEASE; PATHOLOGY; PHYSIOLOGY; REPORTER GENE;

ACETYLATION; ANIMALS; CELL DEATH; CHROMATIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE SILENCING; GENES, REPORTER; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; MICE; MICE, INBRED DBA; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS; TRANSCRIPTION FACTORS;

EID: 84860593660     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8872     Document Type: Article

References (43)

1. Nickells RW. From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma. Can J Ophthalmol. 2007;42:278-287.
2. Libby RT, Li Y, Savinova OV, et al. Susceptibility to neurodegeneration in glaucoma is modified by Bax gene dosage. PLoS Genet. 2005;1:17-26.
3. Whitmore AV, Libby RT, John SWM. Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and compartmentalised processes? Prog Retin Eye Res. 2005;24:639-662.
4. Schlamp CL, Johnson EC, Li Y, Morrison JC, Nickells RW. Changes in Thy1 gene expression associated with damaged retinal ganglion cells. Mol Vis. 2001;7:192-201.
5. Huang W, Fileta J, Guo Y, Grosskreutz CL. Downregulation of Thy1 in retinal ganglion cells in experimental glaucoma. Curr Eye Res. 2006;31:265-271.
6. Yang Z, Quigley HA, Pease ME, et al. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Invest Ophthalmol Vis Sci. 2007;48:5539-5548.
7. Soto I, Oglesby E, Buckingham BP, et al. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci. 2008; 28:548-561.
8. Pelzel HR, Schlamp CL, Nickells RW. Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis (Abstract). BMC Neurosci. 2010;11:62.
9. Weishaupt JH, Klocker N, Bahr M. Axotomy-induced early downregulation of POU-IV class transcription factors Brn-3a and Brn-3b in retinal ganglion cells. J Mol Neurosci. 2005;26:17-25.
10. Shahbazian MD, Grunstein M. Functions of site-specific histone acetylation and deacetylation. Ann Rev Biochem. 2007;76:75-100.
11. Schlamp CL, Thliveris AT, Li Y, et al. Insertion of the βGeo promoter trap into the Fem1c gene of ROSA3 mice. Mol Cell Biol. 2004;24:3794-3803.
12. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci. 2006;7:66.
13. Ding C, Wang P, Tian N. Effect of general anesthetics on IOP in elevated IOP mouse model. Exp Eye Res. 2011;92:512-520.
14. Li Y, Semaan SJ, Schlamp CL, Nickells RW. Dominant inheritance of retinal ganglion cell resistance to optic nerve crush in mice. BMC Neurosci. 2007;8:19.
15. Schlamp CL, Nickells RW. Light and dark cause a shift in the spatial expression of a neuropeptide processing enzyme in the rat retina. J Neurosci. 1996;16:2164-2171.
16. Andreau K, Castedo M, Perfettini JL, et al. Preapoptotic chromatin condensation upstream of the mitochondrial checkpoint. J Biol Chem. 2004;279:55937-55945.
17. Libby RT, Anderson MG, Pang I-H, et al. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci. 2005;22:637-648.
18. Howell GR, Macalinao DG, Sousa GL, et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest. 2011;121:1429-1444.
19. Mosinger Ogilvie J, Deckwerth TL, Knudson CM, Korsmeyer SJ. Suppression of developmental retinal cell death but not photoreceptor degeneration in Bax-deficient mice. Invest Ophthalmol Vis Sci. 1998;39:1713-1720.
20. Jakobs TC, Libby RT, Ben Y, John SWM, Masland RH. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol. 2005;171:313-325.
21. Howell GR, Libby RT, Jakobs TC, et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol. 2007;179:1523-1537.
22. Buckingham BP, Inman DM, Lambert W, et al. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci. 2008;28:2735-2744.
23. Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci USA. 2010;107:5196-5201.
24. Danias J, Lee KC, Zamora MF, et al. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57BL/6 mice. Invest Ophthalmol Vis Sci. 2003;44:5151-5162.
25. Filippopoulos T, Danias J, Chen B, Podos SM, Mittag T. Topographic and morphologic analyses of retinal ganglion cell loss in old DBA/2NNia mice. Invest Ophthalmol Vis Sci. 2006;47:1968-1974.
26. Semaan SJ, Li Y, Nickells RW. A single nucleotide polymorphism in the Bax gene promoter affects transcription and influences retinal ganglion cell death. ASN Neuro. 2010;2:e00032.
27. Soto I, Pease ME, Son JL, et al. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss. Invest Ophthalmol Vis Sci. 2011;52:434-441.
28. Bardai FH, D'Mello SR. Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3β. J Neurosci. 2011;31:1746-1751.
29. Rai M, Soragni E, Chou CJ, et al. Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model. PLoS One. 2010;5:e8825.
30. Sandi C, Pinto RM, Al-Mahdawi S, et al. Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model. Neurobiol Dis. 2011;42:496-505.
31. O'Neill LP, Turner BM. Histone H4 acetylation distinguishes coding regions of the human genome from heterochromatin in a differentiation-dependent but transcription-independent manner. EMBO J. 1995;14:3946-3957.
32. Pazin MJ, Kadonaga JT. What's up and down with histone deacetylation and transcription? Cell. 1997;89:325-328.
33. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
34. Rao L, Perez D, White E. Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol. 1996;135:1441-1455.
35. Wolf CM, Reynolds JE, Morana SJ, Eastman A. The temporal relationship between protein phosphatase, ICE/CED-3 proteases, intracellular acidification, and DNA fragmentation in apoptosis. Exp Cell Res. 1997;230:22-27.
36. Kitazumi I, Tsukahara M. Regulation of DNA fragmentation: the role of caspases and phosphorylation. FEBS Lett. 2011;278:427-441.
37. Saha RN, Pahan K. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ. 2006; 13:539-550.
38. Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 2009;32:591-601.
39. Biermann J, Grieshaber P, Goebel U, et al. Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells. Invest Ophthalmol Vis Sci. 2010;51:526-534.
40. Biermann J, Boyle J, Peilen A, Lagreze WA. Histone deactylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells. Mol Vis. 2011;17: 395-403.
41. Crosson CE, Mani SK, Husain S, Alsarraf O, Menick DR. Inhibition of histone deacetylase protects the retina from ischemic injury. Invest Ophthalmol Vis Sci. 2010;51:3639-3645.
42. Sinn DI, Kim SJ, Chu K, et al. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. Neurobiol Dis. 2007;26:464-472.
43. Cui XS, Xu YN, Shen XH, et al. Trichostatin A modulates apoptoticrelated gene expression and improves embryo viability in cloned bovine embryos. Cell Reprogram. 2011;13:179-189.